The Clinical Times
The Front Page of Medicine

Latest medical news · page 213

The latest headlines across every section, pulled from official and open-access sources.

MedlinePlus (NLM) · Jun 7, 2026

Recovering from a Disaster

Source: General Services Administration Related MedlinePlus Pages: Disaster Preparation and Recovery

MedCity News · Jun 7, 2026

Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm?

Healthcare advocates warn that a new CMS rule on Medicaid work requirement exemptions could increase red tape and cause eligible people to lose coverage. The post Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm? appeared first on MedCity News .

MedlinePlus (NLM) · Jun 7, 2026

Evacuation

Source: Department of Homeland Security Related MedlinePlus Pages: Disaster Preparation and Recovery

MedlinePlus (NLM) · Jun 7, 2026

Wireless Emergency Alerts (WEA)

Source: Federal Communications Commission Related MedlinePlus Pages: Disaster Preparation and Recovery

MedlinePlus (NLM) · Jun 7, 2026

Emergency Communications Tips

Source: Federal Communications Commission Related MedlinePlus Pages: Disaster Preparation and Recovery

ADA (Diabetes) · Jun 7, 2026

ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions

ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions mcarmody Sun, 06/07/2026 - 16:09 Press release ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions NEW ORLEANS, La. June 8, 2026 First Head-to-Head Trial Compares Two Oral GLP-1 RAs Effects on Glucose Control and Weight Changes in Type 2 Diabetes   New data show the benefits of orforglipron…

ADA (Diabetes) · Jun 7, 2026

The American Diabetes Association’s Statement Regarding Nonpartisanship

The American Diabetes Association’s Statement Regarding Nonpartisanship mcarmody Sun, 06/07/2026 - 15:46 Official Statement The American Diabetes Association’s Statement Regarding Nonpartisanship ARLINGTON, Va. June 7, 2026 As many of you are now aware, an incident took place at the American Diabetes Association’s (ADA) Scientific Sessions.  As a 501(c)(3) organization, the ADA has safeguards in place to ensure that it complies with all IRS regulations. This includes maintaining a strictly nonpartisan environment at all organizational events and functions while engaging across party…

MedlinePlus (NLM) · Jun 7, 2026

Essentials for Parenting Teens

Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Parenting

ADA (Diabetes) · Jun 7, 2026

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications mcarmody Sun, 06/07/2026 - 15:18 Press release Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications NEW ORLEANS, La. June 7, 2026 Embargoed until Sunday, June 7, 2026, at 4:30 p.m. CT   Findings Demonstrate Potential for Amylin and GLP-1 Combinations as Next Generation of Weight Loss and Diabetes Treatment   New international study findings demonstrated positive results of the first injectable glucagon-like peptide-1…

ADA (Diabetes) · Jun 7, 2026

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes mcarmody Sun, 06/07/2026 - 13:28 Press release Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes NEW ORLEANS, La. June 7, 2026 Once-Monthly Injection Reduced Triglycerides and the Risk of Acute Pancreatitis; Bi-Weekly Injection Lowered “Bad” Cholesterol and Cardiovascular Events   New data presented at the 2026 Scientific Sessions of the American Diabetes Association ® (ADA) demonstrate the benefits of using medications to address…

MedCity News · Jun 7, 2026

It’s Time for Technology to Lift Maternal Care

Improving maternal safety will not come from adding more data or more devices. It will come from building systems that help clinicians recognize risk earlier and communicate and act with confidence in the moment. The post It’s Time for Technology to Lift Maternal Care appeared first on MedCity News .

BMJ Open · Jun 7, 2026

Use of medicinal herbs in an Iranian population: cross-sectional findings from the Fasa PERSIAN Cohort Study

Objectives To determine the prevalence, patterns and correlates of medicinal herb use in a rural Iranian population and to evaluate demographic and clinical predictors using adjusted regression models. Design Cross-sectional analysis of baseline data from the Fasa Prospective Epidemiological Research Studies in Iran Cohort Study. Setting Sheshdeh, a rural district in southern Iran. Participants 10 143 adults aged 35–70 years enrolled between 2017 and 2019. Primary outcome measures Prevalence of self-reported medicinal herb use during the past year and its associations with demographic…

BMJ Open · Jun 7, 2026

ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiome modulations After kidney transplantation (ENIGMA): study protocol of a prospective longitudinal trial

Introduction In kidney transplantation, immunosuppressive therapy is essential to control alloimmune reactions, prevent graft rejection and improve patient survival rates. However, commonly used drugs like tacrolimus (TAC) and mycophenolate mofetil (MMF) have a narrow therapeutic window and exhibit significant inter- and intra-individual variability in pharmacokinetics (PK) and dose-response relationships. Recent pilot studies suggest that the gut microbiome may influence this variability. Methods and analysis ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut…

BMJ Open · Jun 7, 2026

Global prevalence and determinants of hospital-acquired COVID-19: protocol for a systematic review and meta-analysis

Introduction A proportion of patients hospitalised for COVID-19 acquire the disease during their hospital stay, underscoring the risk of hospital-acquired COVID-19 (HA-COVID-19). This risk is presumed to be high, given how commonly and intensely air and surfaces within hospitals are reportedly contaminated with SARS-CoV-2. However, the true extent of HA-COVID-19 worldwide remains unknown, with limited understanding of factors that influence its occurrence and how these have evolved over time. This review will therefore aim to estimate the pooled prevalence of HA-COVID-19 among hospitalised…

← NewerOlder →

Back to the live front page